LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 21.74 | 1912 | 5768 | 0.3314 | 0.7437 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 21.74 | 6428 | 5768 | 1.1143 | 1.0271 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 21.74 | 6432 | 5768 | 1.1150 | 1.0272 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.48 | 21.74 | 7386 | 5768 | 1.2803 | 1.0623 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.45 | 21.74 | 1516 | 6023 | 0.2517 | 0.6873 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.45 | 21.74 | 6904 | 6023 | 1.1462 | 1.0339 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.45 | 21.74 | 6851 | 6023 | 1.1374 | 1.0320 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 57.45 | 21.74 | 7892 | 6023 | 1.3102 | 1.0677 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.42 | 21.74 | 1675 | 6125 | 0.2735 | 0.7054 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.42 | 21.74 | 7361 | 6125 | 1.2017 | 1.0457 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.42 | 21.74 | 6855 | 6125 | 1.1191 | 1.0278 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 59.42 | 21.74 | 8215 | 6125 | 1.3411 | 1.0735 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.39 | 21.74 | 1417 | 6112 | 0.2318 | 0.6711 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.39 | 21.74 | 7747 | 6112 | 1.2673 | 1.0591 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.39 | 21.74 | 6892 | 6112 | 1.1275 | 1.0297 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.39 | 21.74 | 8579 | 6112 | 1.4035 | 1.0851 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.36 | 21.74 | 1223 | 6191 | 0.1975 | 0.6393 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.36 | 21.74 | 8156 | 6191 | 1.3174 | 1.0688 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.36 | 21.74 | 6429 | 6191 | 1.0384 | 1.0093 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.36 | 21.74 | 8910 | 6191 | 1.4392 | 1.0913 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.33 | 21.74 | 1093 | 6235 | 0.1753 | 0.6158 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.33 | 21.74 | 8641 | 6235 | 1.3858 | 1.0815 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.33 | 21.74 | 5984 | 6235 | 0.9597 | 0.9899 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 66.33 | 21.74 | 9157 | 6235 | 1.4685 | 1.0964 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 68.30 | 21.74 | 891 | 6244 | 0.1427 | 0.5757 | MN20160310_N01 | E09 |